Two Sharp with ET: Food safety shock hits Blinkit, Zepto; rare-earth crisis rattles auto sector
Zomato's Blinkit and Zepto are under fire as FDA raids expose expired goods and hygiene issues, shaking investor confidence. Meanwhile, a rare-earth export squeeze from China halts car production at Ford and Suzuki. India faces food safety fears at home and supply chain tremors abroad. All of this in today's Two Sharp with ET. Show more 05:49
04:16
06:46
07:02
02:22
01:20
05:13
04:31
02:05
02:05
04:06
06:16
01:28
07:08
01:38
04:40
03:48
02:17
06:32
01:25
02:35
04:55
06:21
04:31
01:40
06:04
05:39
07:05
02:22
05:26
01:45
02:41
02:40
01:29
05:00
03:14
04:45
06:38
01:11
04:28
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 hours ago
- Time of India
Myntra launches quick commerce service in Delhi-NCR, Mumbai: How it is different from Blinkit, Zepto and others
Myntra has rolled out its "M-Now" 30-minute delivery service to Delhi-NCR and Mumbai, following a successful pilot in Bengaluru, a report has said. Unlike Blinkit, Zepto and other food-related quick commerce platforms, M-Now will specifically focus on delivering clothes, including from premium brands, in 30-minutes. Notably, Blinkit and Zepto also deliver some basic apparels such as tees and shorts. The M-Now service, first trialed in Bengaluru last December with around 10,000 SKUs, now offers collections from nearly 600 brands. Customers in the expanded zones can now get rapid delivery on items from popular names like Vero Moda, Mango, Calvin Klein, Tommy Hilfiger, Levi's and even luxury beauty and accessory brands such as Dyson, YSL, Prada, Carolina Herrera, and Huda Beauty, as per a report by The Economic Times. Myntra CEO Nandita Sinha had previously indicated the company's plans to bring the service to Mumbai, New Delhi and Pune. She noted a "significant demand from fashion-first and trend-focused premium customers for quick deliveries." Other fashion brands exploring quick-delivery by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Laticínios com até 26% OFF aqui na Shopper! Compre já Undo Myntra's move is part of a larger trend in India's e-commerce landscape, where fashion platforms like Ajio and Nykaa, along with new-age brands such as Newme, Slikk and Blip, are all exploring ultra-fast delivery. This momentum was initially sparked by quick commerce pioneers like Blinkit, Instamart, and Zepto, who expanded beyond groceries to include fashion and apparel from brands like Jockey, Manyavar, Puma, and Adidas. The report also pointed out the challenges, saying that one key hurdle is customer behaviour. As per as Snitch founder Siddharth Dungarwal, while initial interest in fast delivery is high, shoppers often revert to purchasing only basic wardrobe essentials like black t-shirts or shirts through these services. AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Hans India
a day ago
- Hans India
ZeroHarm Eyes Rs 150 Crore Milestone by FY 2025 -'26, Accelerates Global Expansion into GCC
ZeroHarm Sciences, India's pioneering clean-label nutraceutical company, is set to accelerate its global footprint with a focused expansion into the GCC markets, including the UAE and the broader Middle East. Following a remarkable 10× revenue growth over the past two years and operating at a healthy ~20% EBITDA margin, the company closed the last fiscal year with 71 crore in gross revenue with an exit ARR of 90 crores. In the current fiscal, ZeroHarm is aiming for ₹150 crore in gross revenue, driven by strong domestic and global momentum and increasing traction in the United States, which now contributes nearly 30% of its overall revenue. At the heart of ZeroHarm's global success is its patented ZeroHarm BioEnhance platform, a pharma-grade nanotechnology that encapsulates plant-based actives at the nanoscale, dramatically enhancing their bioavailability by up to 5×, ensuring faster onset, precise dosing, and residue-free delivery. This breakthrough, backed by granted patents and deep R&D, makes ZeroHarm the first Indian company to bring pharmaceutical nanotech into nutraceuticals at scale. ZeroHarm's US FDA, CE, and ISO-certified formulations are backed by government-led clinical trials, with documented claims for 15 products, setting it apart in a market rife with unverified health claims. Today, the company offers over 70 targeted, condition-specific products spanning diabetes, arthritis, PCOS, liver and kidney health, immunity, and oncology support, with over million units sold across India to date. Backed by a fully owned, nanotech-enabled manufacturing facility, ZeroHarm can produce up to ₹250 crore worth of finished goods annually, making it one of the few Indian nutraceutical brands with true end-to-end production capabilities. To support its international expansion, ZeroHarm has acquired a dedicated manufacturing and R&D facility in the United States, enhancing local supply chain efficiency, fast-tracking formulation innovation, and enabling closer clinical and regulatory collaborations in key global markets. The U.S. infrastructure also gives ZeroHarm a significant strategic edge in developed markets, where stringent compliance standards often limit entry for Indian nutraceutical brands reliant on contract manufacturing. 'The global nutraceutical market is shifting, consumers are demanding not just clean labels, but clinical credibility. At ZeroHarm, we've combined deep R&D with pharma-grade nanotechnology to raise the bar for efficacy, safety, and transparency in preventive wellness. Our entry into the GCC is a natural extension of the trust we've built in India and the U.S., and a significant step toward making evidence-backed, plant-based therapeutics accessible to global consumers,' said Sachin Darbarwar, Founder & CEO, ZeroHarm Sciences. With distribution agreements and regulatory filings already underway, the company will also launch in the UK aside from the GCC markets by Q3 2025, introducing its clinically tested product lines via pharmacies, e-commerce platforms, and integrative practitioner networks.
United News of India
a day ago
- United News of India
Trump gives Iran a 2-week window to open negotiations before considering US military action
Washington, June 20 (UNI) Mulling over US options, President Donald Trump has said that it will give Iran a two-week window to open negotiations before considering direct US military intervention in the conflict, reports CNN. White House officials have expressed hope that Trump's hardline stance, coupled with Israel's relentless strikes against Iranian missile infrastructure – which Tel Aviv says has decimated two-thirds of Tehran's missile launching capabilities – will open windows for negotiations, and allow both countries to come to a deal. For its part, Iran has refused to budge an inch, with Supreme Leader Ayatollah Ali Khomeini warning of serious repercussions for the US, if it intervenes militarily. In a statement read out by the White House press secretary Karoline Leavitt said that there was a "substantial chance of negotiations" with Iran, though did not confirm anything. Meanwhile, CBS News has reported that while Trump has approved plans to attack Iran, and has been diverting military supplies to American bases in the Middle East, he has still not decided whether or not to go through with military attacks. He is reportedly weighing an attack on Iran's underground uranium enrichment facility at Fordo, and is one of the most difficult areas to strike. The Fordo complex is built deep within northern Iran's rugged, remote mountains and is designed to withstand air strikes, with its underground location shielding it from conventional bombs. Despite the Israeli military's capabilities, the Fordo complex presents a very unique challenge for the IDF, because of the sheer depth of its underground facilities. To cause any meaningful damage to the site it would need to be targeted by a 'bunker buster' munition that is able to penetrate deep below the surface. While Israel possesses the resources to destroy underground bunkers, it does not have the bombing capabilities required to destroy a complex like the Ford plant. However, the US is believed to have a bomb which might do the trick – the GBU-57 Massive Ordnance Penetrator (MOP) – which can strike 61m deep. But even that may prove insufficient to destroy the Ford, as the tunnels go 80-90m below the surface. UNI ANV GNK
